How is biotech firm Novozymes integrating the SDGs?

By Adva Saldinger 24 June 2016

Via Devex YouTube channel

For global biotech company Novozymes, failing to incorporate the Sustainable Development Goals into the way they work is not an option.

The company is embedding an SDG assessment framework in its innovation pipeline and using it to help determine what products or models it will take to market, said Claus Stig Pedersen, Novozyme’s head of corporate sustainability affairs.

Devex checks in on this approach a year after its inception to find out how it’s working and what it means for the company.

To learn more about how Novozymes is looking at the SDGs, watch the video above.

Watch more international development news online, and subscribe to The Development Newswire to receive the latest from the world’s leading donors and decision-makers — emailed to you FREE every business day.

About the author

Adva%2520saldinger%2520photo
Adva Saldinger@AdvaSal

As a Devex Impact associate editor, Adva leads coverage of the intersection of business and international development. From partnerships to trade and social entrepreneurship to impact investing, she enjoys exploring the role the private sector and private capital play in development. Previously, she has worked as a reporter at newspapers in both the U.S. and South Africa. Most recently, she has been ghostwriting a memoir for a former child slave and NGO founder in Ghana.


Join the Discussion